We are live on
!
Find out more
Rubric Capital Management (New York) Portfolio holdings
AUM
$10.9B
Turnover
31.68%
1-Year Est. Return
70.31%
This Fund
S&P 500
This Quarter
Est. Return
+19.17%
1 Year Est. Return
+70.31%
3 Year Est. Return
+250.68%
5 Year Est. Return
+304.91%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.46B
(+15%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
13.59%
Top 10 Holdings %
Top 10 Hldgs %
46.43%
Holding
101
New
18
Increased
33
Reduced
12
Closed
14
Avg Time Held Equity + Options
1.6
years
Top 10 Avg Time Held Equity + Options
1.4
years
Top 20 Avg Time Held Equity + Options
1.3
years
Avg Time Held Equity only
1.6
years
Top 10 Avg Time Held Equity only
1.4
years
Top 20 Avg Time Held Equity only
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fluor
FLR
|
+$246M |
| 2 |
Amazon
AMZN
|
+$226M |
| 3 |
Gildan
GIL
|
+$178M |
| 4 |
Zoom
ZM
|
+$167M |
| 5 |
PennyMac Financial
PFSI
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Energy
CEG
|
+$200M |
| 2 |
Akamai
AKAM
|
+$149M |
| 3 |
Telephone and Data Systems
TDS
|
+$77.9M |
| 4 |
Adeia
ADEA
|
+$63.7M |
| 5 |
Mercury Insurance
MCY
|
+$60.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.1% |
| 2 | Utilities | 18.51% |
| 3 | Industrials | 14.51% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Energy | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Galaxy Digital Inc
GLXY
$3.14B
| $64.1M | 0.59% |
+2,343,169
| New | +$65.2M |
2026 Q2
0 quarters
|
|
52
Venture Global Inc
VG
$31.8B
| $60.2M | 0.55% |
5,410,280
+3,910,280
| +261% | +$49.5M |
2026 Q1
1 quarter
|
|
53
Establishment Labs
ESTA
$1.76B
| $59.1M | 0.54% |
+688,325
| New | +$49.4M |
2026 Q2
0 quarters
|
|
54
QuidelOrtho
QDEL
$885M
| $57.9M | 0.53% |
3,306,281
| – | – |
2023 Q3
11 quarters
|
|
55
Alvotech
ALVO
$1.78B
| $57.8M | 0.53% |
+15,677,093
| New | +$56M |
2026 Q2
0 quarters
|
|
56
Target Hospitality
TH
$1.51B
| $52.7M | 0.48% |
2,586,389
+396,933
| +18% | +$6.64M |
2024 Q4
6 quarters
|
|
57
DNOW Inc
DNOW
$2.83B
| $50.6M | 0.46% |
3,898,635
+2,631,108
| +208% | +$34.2M |
2026 Q1
1 quarter
|
|
58
Prothena Corp
PRTA
$429M
| $49M | 0.45% |
5,000,000
| – | – |
2025 Q3
3 quarters
|
|
59
Trevi Therapeutics
TRVI
$1.69B
| $46.7M | 0.43% |
2,504,513
-1,207,860
| -33% | -$17.6M |
2022 Q2
16 quarters
|
|
60
Collegium Pharmaceutical
COLL
$755M
| $46.3M | 0.42% |
1,279,611
| – | – |
2020 Q1
25 quarters
|
|
61
Arbutus Biopharma
ABUS
$836M
| $36.2M | 0.33% |
7,532,937
+906,548
| +14% | +$3.98M |
2024 Q2
8 quarters
|
|
62
Versigent PLC
VGNT
$3.13B
| $35.9M | 0.33% |
+855,163
| New | +$34.1M |
2026 Q2
0 quarters
|
|
63
Xperi
XPER
$243M
| $34.1M | 0.31% |
4,143,744
| – | – |
2022 Q4
14 quarters
|
|
64
Orthofix Medical
OFIX
$382M
| $34M | 0.31% |
3,721,715
| – | – |
2023 Q1
13 quarters
|
|
65
TripAdvisor
TRIP
$1.09B
| $33.4M | 0.31% |
+2,439,110
| New | +$27.6M |
2026 Q2
0 quarters
|
|
66
Mativ Holdings
MATV
$619M
| $30.1M | 0.28% |
3,982,442
| – | – |
2022 Q3
15 quarters
|
|
67
Liberty Latin America Class A
LILA
$1.58B
| $29.6M | 0.27% |
3,777,654
-1,742,346
| -32% | -$9.71M |
2025 Q3
3 quarters
|
|
68
Biohaven
BHVN
$1.63B
| $25.6M | 0.24% |
+1,721,493
| New | +$18.5M |
2026 Q2
0 quarters
|
|
69
Vistance Networks Inc
VISN
$1.34B
| $25.6M | 0.23% |
2,000,000
| – | – |
2026 Q1
1 quarter
|
|
70
ANI Pharmaceuticals
ANIP
$1.66B
| $21.4M | 0.2% |
+258,131
| New | +$20.7M |
2026 Q2
0 quarters
|
|
71
uniQure
QURE
$1.51B
| $18.8M | 0.17% |
+408,581
| New | +$10.7M |
2026 Q2
0 quarters
|
|
72
Hudson Pacific Properties
HPP
$559M
| $15.5M | 0.14% |
+1,019,598
| New | +$11.2M |
2026 Q2
0 quarters
|
|
73
Seaport Entertainment Group
SEG
$292M
| $15.1M | 0.14% |
568,530
| – | – |
2024 Q3
7 quarters
|
|
74
GDS Holdings
GDS
$4.62B
| $14.6M | 0.13% |
+485,873
| New | +$18.8M |
2026 Q2
0 quarters
|
|
75
Heron Therapeutics
HRTX
$68.5M
| $12.8M | 0.12% |
30,046,828
| – | – |
2022 Q3
15 quarters
|
|
Similar funds
Rubric Capital Management (New York)'s Q2 2026 Portfolio in Review
As of Q2 2026, Rubric Capital Management (New York) held 101 positions worth $10.9B, up 15% from $9.44B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Rubric Capital Management (New York) deployed $1.48B of net new capital in Q2 2026, opening 18 new positions and adding to 33 existing holdings. Its largest new stake was Fluor: 5,017,248 shares worth $263M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 28% a quarter earlier, followed by Utilities and Industrials.
On the sell side, the largest reduction was Adeia, an estimated $63.7M trimmed.
- Rubric Capital Management (New York)'s largest Q2 2026 buy was Fluor: 5,017,248 shares worth $263M.
- Rubric Capital Management (New York) added most to Gildan in Q2 2026, an estimated $178M increase.
- Rubric Capital Management (New York)'s biggest Q2 2026 reduction was Adeia, cutting an estimated $63.7M.
- Rubric Capital Management (New York) fully exited Constellation Energy in Q2 2026, selling an estimated $200M.
- Rubric Capital Management (New York)'s ten largest holdings make up 46% of its $10.9B portfolio in Q2 2026.
- Rubric Capital Management (New York) opened 18 new positions and closed 14 in Q2 2026.
- Rubric Capital Management (New York)'s portfolio value rose 15% quarter-over-quarter to $10.9B.
Based on Rubric Capital Management (New York)'s 13F filing for Q2 2026, filed 14 Aug 2026.